Characterization of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli Among Iranian Kidney Transplant Patients

References

• Vidal E, Torre‐Cisneros J, Blanes M, et al. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis. 2012;14:595–603. doi:10.1111/j.1399-3062.2012.00744.x22650416
   PubMed Web of Science ®Google Scholar
• Farajzadeh Sheikh A, Shahin M, Shokoohizadeh L, Halaji M, Shahcheraghi F, Ghanbari F. Molecular epidemiology of colistin-resistant Pseudomonas aeruginosa producing NDM-1 from hospitalized patients in Iran. Iran J Basic Med Sci. 2019;22:38–42. doi:10.22038/ijbms.2018.29264.709630944706
   PubMed Web of Science ®Google Scholar
• Rawat D, Nair D. Extended-spectrum β-lactamases in gram negative bacteria. J Glob Infect Dis. 2010;2:263–274. doi:10.4103/0974-777X.6853120927289
   PubMedGoogle Scholar
• Azap OK, Arslan H, Serefhanoglu K, et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010;16(2):147–151. doi:10.1111/j.1469-0691.2009.02941.x19689464
   PubMed Web of Science ®Google Scholar
• Azap O, Togan T, Yesilkaya A, Arslan H, Haberal M. Antimicrobial susceptibilities of uropathogen Escherichia coli in renal transplant recipients: dramatic increase in ciprofloxacin resistance. Transplant Proc. 2013;45(3):956–957. doi:10.1016/j.transproceed.2013.03.00623622597
   PubMed Web of Science ®Google Scholar
• Paul R. State of the globe: rising antimicrobial resistance of pathogens in urinary tract infection. J Glob Infect Dis. 2018;10(3):117–118. doi:10.4103/jgid.jgid_104_1730166807
   PubMed Web of Science ®Google Scholar
• Faghri J, Nouri S, Jalalifar S, Zalipoor M, Halaji M. Investigation of antimicrobial susceptibility, class I and II integrons among Pseudomonas aeruginosa isolates from hospitalized patients in Isfahan, Iran. BMC Res Notes. 2018;11(1):806. doi:10.1186/s13104-018-3901-930419962
   PubMedGoogle Scholar
• Farajzadah Sheikh A, Goodarzi H, Yadyad MJ, et al. Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection. Infect Drug Resist. 2019;12:2039–2047. doi:10.2147/IDR.S19976431410031
   PubMed Web of Science ®Google Scholar
• Alevizakos M, Nasioudis D, Mylonakis E. Urinary tract infections caused by ESBL-producing Enterobacteriaceae in renal transplant recipients: a systematic review and meta-analysis. Transpl Infect Dis. 2017;19.
   Google Scholar
• Machado E, Cantón R, Baquero F, et al. Integron content of extended-spectrum-β-lactamase-producing Escherichia coli Strains over 12 years in a single hospital in Madrid, Spain. Antimicrob Agents Chemother. 2005;49:1823. doi:10.1128/AAC.49.2.612-618.200515855502
   PubMed Web of Science ®Google Scholar
• Bodro M, Sanclemente G, Lipperheide I, et al. Impact of antibiotic resistance on the development of recurrent and relapsing symptomatic urinary tract infection in kidney recipients. Am J Transplant. 2015;15:1021–1027. doi:10.1111/ajt.1307525676738
   PubMed Web of Science ®Google Scholar
• Kaur M, Aggarwal A. Occurrence of the CTX-M, SHV and the TEM genes among the extended spectrum beta-lactamase producing isolates of enterobacteriaceae in a tertiary Care Hospital of North India. J Clin Diagn Res. 2013;7:642–645. doi:10.7860/JCDR/2013/5081.287223730637
   PubMedGoogle Scholar
• Ur Rahman S, Ali T, Ali I, Khan NA, Han B, Gao J. The growing genetic and functional diversity of extended spectrum beta-lactamases. Biomed Res Int. 2018;2018:9519718. doi:10.1155/2018/951971829780833
   PubMed Web of Science ®Google Scholar
• Hollyer I, Ison MG. The challenge of urinary tract infections in renal transplant recipients. Transpl Infect Dis. 2018;20:e12828. doi:10.1111/tid.1282829272071
   PubMed Web of Science ®Google Scholar
• Jouini A, Vinue L, Slama KB, et al. Characterization of CTX-M and SHV extended-spectrum beta-lactamases and associated resistance genes in Escherichia coli strains of food samples in Tunisia. J Antimicrob Chemother. 2007;60:1137–1141. doi:10.1093/jac/dkm31617855726
   PubMed Web of Science ®Google Scholar
• Wayne P. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fourth Informational Supplement, M100-S24. Clinical Laboratory Standards Institute (CLSI) 2014;34.
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
   PubMed Web of Science ®Google Scholar
• Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L. Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother. 2003;47:3724–3732. doi:10.1128/AAC.47.12.3724-3732.200314638473
   PubMed Web of Science ®Google Scholar
• Wiegand I, Geiss HK, Mack D, Sturenburg E, Seifert H. Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. J Clin Microbiol. 2007 45:1167–1174. doi:10.1128/JCM.01988-0617287329
   PubMed Web of Science ®Google Scholar
• Shams SF, Eidgahi ES, Lotfi Z, et al. Urinary tract infections in kidney transplant recipients 1(st) year after transplantation. J Res Med Sci. 2017;22:20. doi:10.4103/1735-1995.20027428458711
   PubMed Web of Science ®Google Scholar
• Li B, Webster TJ. Bacteria antibiotic resistance: new challenges and opportunities for implant-associated orthopedic infections. J Orthop Res. 2018;36:22–32. doi:10.1002/jor.2365628722231
   PubMed Web of Science ®Google Scholar
• Kashef Nejad M, Jazani NH, Sharifi Y. Urinary tract infections among kidney transplant patients due to extended-spectrum beta-lactamase-producing bacteria. Microb Pathog. 2017;107:276–279. doi:10.1016/j.micpath.2017.03.04628390979
   PubMed Web of Science ®Google Scholar
• Pinheiro H, Mituiassu A, Carminatti M, Braga A, Bastos M. Urinary tract infection caused by extended-spectrum beta-lactamase–producing bacteria in kidney transplant patients In: Transplant Proc. Elsevier; 2010:486–487.
   Google Scholar
• Pilmis B, Scemla A, Join-Lambert O, et al. ESBL-producing enterobacteriaceae-related urinary tract infections in kidney transplant recipients: incidence and risk factors for recurrence. Infect Dis. 2015;47(10):714–718. doi:10.3109/23744235.2015.1051107
   PubMed Web of Science ®Google Scholar
• Ramadas P, Rajendran PP, Krishnan P, et al. Extended-spectrum-beta-lactamase producing bacteria related urinary tract infection in renal transplant recipients and effect on allograft function. PLoS One. 2014;9(3):e91289. doi:10.1371/journal.pone.009128924637786
   PubMed Web of Science ®Google Scholar
• Goncalves LF, de Oliveira Martins-junior P, de Melo ABF, et al. Multidrug resistance dissemination by extended-spectrum beta-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region, Brazil. J Glob Antimicrob Resist. 2016;6:1–4. doi:10.1016/j.jgar.2016.02.00327530830
   PubMed Web of Science ®Google Scholar
• Nabti LZ, Sahli F, Radji N, et al. High prevalence of multidrug-resistant Escherichia coli in urine samples from inpatients and outpatients at a tertiary care hospital in Setif, Algeria. Microb Drug Resist. 2019;25:386–393. doi:10.1089/mdr.2018.031430676258
   PubMed Web of Science ®Google Scholar
• Zhu FH, Rodado MP, Asmar BI, Salimnia H, Thomas R, Abdel-Haq N. Risk factors for community acquired urinary tract infections caused by extended spectrum beta-lactamase (ESBL) producing Escherichia coli in children: a case control study. Infect Dis (Lond). 2019;51:802–809. doi:10.1080/23744235.2019.165412731429616
   PubMed Web of Science ®Google Scholar
• Pourakbari B, Ferdosian F, Mahmoudi S, et al. Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran. Braz J Microbiol. 2012;43:766–769. doi:10.1590/S1517-8382201200020004124031888
   PubMed Web of Science ®Google Scholar
• Shahbazi S, Asadi Karam MR, Habibi M, Talebi A, Bouzari S. Distribution of extended-spectrum beta-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist. 2018;14:118–125. doi:10.1016/j.jgar.2018.03.00629581075
   PubMed Web of Science ®Google Scholar
• Hashemizadeh Z, Kalantar-Neyestanaki D, Mansouri S. Clonal relationships, antimicrobial susceptibilities, and molecular characterization of extended-spectrum beta-lactamase-producing Escherichia coli isolates from urinary tract infections and fecal samples in Southeast Iran. Rev Soc Bras Med Trop. 2018;51:44–51. doi:10.1590/0037-8682-0080-201729513841
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh M, Tavakoli M, Yaslianifard S, Asadi E, Golmohammadi R, Mirnejad R. Genetic diversity and antibiotic susceptibility of uropathogenic Escherichia coli isolates from kidney transplant recipients. Infect Drug Resist. 2019;12:1795–1803.31372004
   PubMed Web of Science ®Google Scholar
• Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15(1):545. doi:10.1186/s12879-015-1282-426607324
   PubMed Web of Science ®Google Scholar
• Shapouri Moghaddam A, Arfaatabar M, Tavakol Afshari J, Shakerimoghaddam A, Mohammadzamani Z, Khaledi A. Prevalence and antimicrobial resistance of bacterial uropathogens isolated from iranian kidney transplant recipients: a systematic review and meta-analysis. Iran J Public Health. 2019;48:2165–2176.31993384
   PubMed Web of Science ®Google Scholar
• Shokouhi Mostafavi SK, Najar-Peerayeh S, Mohabbati Mobarez A, Kardoust Parizi M. Serogroup distribution, diversity of exotoxin gene profiles, and phylogenetic grouping of CTX-M-1- producing uropathogenic Escherichia coli. Comp Immunol Microbiol Infect Dis. 2019;65:148–153. doi:10.1016/j.cimid.2019.05.00331300106
   PubMed Web of Science ®Google Scholar
• Shahraki-Zahedani S, Moghadampour M, Bokaeian M, Ansari-Moghaddam A. Prevalence of CTX-M-8 and CTX-M-15 type extended-spectrum beta-lactamases between Klebsiella pneumoniae spp. isolated from Zahedan, Southeast Iran. J Chemother. 2016;28:343–345. doi:10.1179/1973947815Y.000000000825801185
   PubMed Web of Science ®Google Scholar
• Zeighami H, Haghi F, Hajiahmadi F. Molecular characterization of integrons in clinical isolates of betalactamase-producing Escherichia coli and Klebsiella pneumoniae in Iran. J Chemother. 2015;27:145–151. doi:10.1179/1973947814Y.000000018024571248
   PubMed Web of Science ®Google Scholar
• Espinar MJ, Miranda IM, Costa-de-Oliveira S, Rocha R, Rodrigues AG, Pina-Vaz C. Urinary tract infections in kidney transplant patients due to escherichia coli and klebsiella pneumoniae-producing extended-spectrum beta-lactamases: risk factors and molecular epidemiology. PLoS One. 2015;10:e0134737. doi:10.1371/journal.pone.013473726237422
   PubMed Web of Science ®Google Scholar
• Namaei MH, Yousefi M, Ziaee M, et al. First report of prevalence of CTX-M-15-producing Escherichia coli O25b/ST131 from Iran. Microb Drug Resist. 2017;23:879–884. doi:10.1089/mdr.2016.027228437226
   PubMed Web of Science ®Google Scholar